Kite Pharma, Inc.
May 26, 2015

Kite Pharma to Present at the Jefferies 2015 Global Healthcare Conference

SANTA MONICA, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc., (Nasdaq:KITE), today announced that Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on June 2, 2015 at 11:00am Eastern Time. The conference will be held in New York, NY.

A live audio webcast of the presentation can be accessed through the Calendar of Events section of the Company's website at ir.kitepharma.com. A replay of the webcast will be available on the Company's website for two weeks following the presentation.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. ┬áKite is based in┬áSanta Monica, CA.

CONTACT: Kite Pharma

         Cynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer

         310-824-9999



         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns and Carol Werther

         Burns McClellan

         212-213-0006

         jjackson@burnsmc.com

         lburns@burnsmc.com

         cwerther@burnsmc.com

Kite Pharma, Inc. logo

Source: Kite Pharma, Inc.

News Provided by Acquire Media